American Oncology Network Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +0.0% | -162.2% | – | – | |
| – | – | – | – | +10.8% | -5.5% | -5.8% | +5.9% | +8.8% | +2.8% | -1.0% | +19.3% | – | |
| – | – | – | – | – | – | – | -100.0% | – | +0.0% | -85.0% | +109.5% | – | |
| – | – | – | – | – | +5,030.7% | – | – | – | – | – | – | – | |
| – | -71.5% | +14,244.9% | -1,303.5% | – | – | +310.9% | -2.5% | +950.9% | -165.8% | – | – | – | |
| – | +0.0% | -100.0% | – | +29.6% | +48.4% | +131.1% | -71.1% | +49.9% | +0.0% | +56.1% | -2.0% | – | |
| – | -97.9% | – | -854.0% | +183.6% | -98.1% | +692,058.4% | -96.9% | – | +0.0% | +885.5% | -214.8% | – | |
| – | – | – | – | – | -97.5% | -84.0% | -93.3% | +10.2% | +0.0% | -100.0% | – | – | |
| – | – | – | – | +0.0% | +21.9% | – | – | – | +1,146.5% | -33.2% | -1.4% | – | |
| – | -100.0% | +24,912.7% | -102.6% | -74.5% | – | +122,401.3% | -100.1% | -13.9% | +0.0% | +414.6% | – | – | |
| – | – | – | – | – | – | – | -144.8% | – | +0.0% | -131.0% | – | – | |
| – | – | – | – | – | – | – | – | – | +0.0% | -184.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 19, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.